Quince Therapeutics, Inc. (QNCX) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -7.63M | -10.48M | -9.93M | -11.41M | -9.6M | -7.55M | -7.26M | -8.74M | -8.35M | -6.08M | -4.82M | -3.83M | -3.57M | -5.83M | -6.7M | -15.41M | -16.09M | -14.42M | -17.34M | -17.56M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 20.56% | -38.78% | -36.75% | -30.62% | -14.94% | -24.25% | -50.68% | -128.35% | -134.04% | -4.16% | 28.06% | 75.17% | 77.82% | 59.53% | 61.38% | 12.23% | -18.23% | -8.6% | -40.18% | -22.03% |
| Net Income | 35.91M | -39.46M | -13.44M | -16.05M | -15.03M | -12.46M | -5.49M | -27.73M | -11.15M | -8.89M | -5.35M | -4.89M | -12.25M | -5.53M | -7.92M | -16.56M | -21.64M | -23.4M | -21.71M | -21.75M |
| Depreciation & Amortization | 36K | 39K | 36K | 35K | 32K | 16K | 86K | 44K | 40K | 304K | 0 | 1K | 17K | 42K | 40K | 84K | 38K | 84K | 87K | 87K |
| Stock-Based Compensation | 1.29M | 1.19M | 1.25M | 1.27M | 1.39M | 1.13M | 1.12M | 1.22M | 1.27M | 1.09M | 1.33M | 1.32M | 1.48M | 1.63M | 694K | 5.05M | 9.24M | 8.49M | 7.62M | 6.75M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.82M | 0 | 0 | -248K | 0 | 0 | -284K | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -30.41M | 15.28M | 2.03M | 5.2M | 1.96M | 1.87M | -2.83M | 19.14M | 2.29M | 3M | -719K | -465K | 5.83M | -208K | 771K | 215K | 135K | 199K | 248K | 336K |
| Working Capital Changes | -14.45M | 12.47M | 194K | -1.87M | 2.05M | 1.9M | -152K | -1.42M | -805K | 250K | -79K | 201K | 1.6M | -1.77M | -281K | -3.92M | -3.86M | 205K | -3.59M | -2.98M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 5.91M | -1.15M | 1.63M | -1.44M | 22K | 1.35M | -825K | 342K | 59K | -127K | 55K | -1.3M | 1.08M | -614K | -665K | -3.48M | -1.18M | 2.03M | -4.31M | 4.35M |
| Cash from Investing | 12M | 8.07M | -1.78M | 6.04M | 10.9M | 10.87M | 7.11M | -4.98M | 8.91M | 5.39M | 3.63M | -20.32M | 5.54M | 18.67M | -8.83M | -5.25M | 13.41M | 20.92M | 766K | 5.62M |
| Capital Expenditures | 0 | -4K | -74K | -126K | -148K | -133K | -46K | -39K | -39K | -24K | 0 | 0 | -136K | -78K | -50K | 0 | -5K | -44K | 0 | -99K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.12M | 0 | 0 | 0 | 0 | 0 | 0 | 135K | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 355K | 490K | 0 | 0 | 0 | -500K | -500K | 0 | 90K | 0 | 35K | 10.63M | -135K | 0 | 0 | 0 |
| Cash from Financing | 9.44M | 2.03M | 1.38M | 14.41M | 87K | 0 | -5M | 35K | 190K | 57K | 10K | 26K | 50K | -18K | -5K | 108K | 622K | 990K | 4.71M | 672K |
| Debt Issued (Net) | -5.54M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -6K | 0 | 0 | -6K | -18K | -19K | -12K | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 14.99M | 2.03M | 1.38M | 14.41M | 87K | 0 | 0 | 35K | 190K | 57K | 10K | 26K | 0 | 0 | 0 | 0 | 608K | 990K | 4.71M | 672K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 0 | -5M | 0 | 0 | 6K | 0 | 0 | 56K | 0 | 14K | 120K | 14K | 0 | 0 | 0 |
| Net Change in Cash | 12.35M | -643K | -10.37M | 9.05M | 1.56M | 3.54M | -5.21M | -13.92M | 1.06M | -880K | -1.02M | -24.06M | 2.13M | 12.77M | -15.12M | -20.64M | -2.16M | 7.52M | -11.84M | -11.27M |
| Free Cash Flow | -7.63M | -10.48M | -10M | -11.54M | -9.75M | -7.68M | -7.31M | -8.78M | -8.39M | -6.1M | -4.82M | -3.83M | -3.71M | -5.91M | -6.75M | -15.41M | -16.1M | -14.46M | -17.34M | -17.66M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | 21.77% | -36.43% | -36.9% | -31.48% | -16.17% | -25.94% | -51.64% | -129.37% | -126.5% | -3.2% | 28.59% | 75.17% | 76.98% | 59.11% | 61.09% | 12.72% | -17.95% | -8.85% | -39.96% | -22.57% |
| FCF per Share | -30.45 | -41.86 | -37.08 | -49.44 | -44.37 | -35.53 | -33.85 | -40.74 | -39.02 | -29.79 | -26.71 | -21.31 | -20.67 | -32.73 | -37.89 | -94.96 | -106.83 | -97.17 | -116.52 | -119.38 |
| FCF Conversion (FCF/Net Income) | -0.21x | 0.27x | 0.74x | 0.71x | 0.64x | 0.61x | 1.32x | 0.32x | 0.75x | 0.68x | 0.90x | 0.78x | 0.29x | 1.05x | 0.85x | 0.93x | 0.74x | 0.62x | 0.80x | 0.81x |
| Interest Paid | 0 | 0 | 0 | 64K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |